SGO 2019: Dendritic Cell–Based Immunotherapy Shows “Dramatic” Response for Ovarian Cancer

Leggi l'articolo originale


The phase II trial evaluated dendritic cell–based immunotherapy with concomitant administration of chemotherapy vs chemotherapy alone.

Lascia un commento